Survivors Against TB urges immediate action to address critical anti-TB drug shortages EP News Bureau Aug 28, 2023 Survivors Against TB (SATB), a collective of TB survivors, experts, and advocates, has written to Mansukh Mandaviya, the Minister…
ZeNix trial shows effectiveness of BPaL regimen for TB can be maintained with reduced dosing of… EP News Bureau Sep 6, 2022 The results from the trial, which was led by TB Alliance, were published in the 'New England Journal of Medicine'
Trial reveals BPaL regimen for highly drug-resistant TB is effective even with reduced dose of… EP News Bureau Jul 15, 2021 This regimen reduces the treatment time for highly drug-resistant forms of TB from 18 months or longer to a six-month duration
